...
首页> 外文期刊>Viral immunology >Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India
【24h】

Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India

机译:流感A(H1N1)PDM09病毒自然感染后的血聚凝集抑制抗体反应:来自印度卡纳塔卡的Truthahalli的横截面研究

获取原文
获取原文并翻译 | 示例

摘要

Influenza viruses are major respiratory pathogens that cause seasonal epidemics and occasional pandemics. Immune response to influenza viruses is majorly targeted against the hemagglutinin antigen. A laboratory-based retrospective cross-sectional study was conducted on 50 acute and 50 follow-up samples to assess the immune response to influenza A(H1N1)pdm09 virus after natural infection and detect the presence of pre-existing antibodies against influenza A(H3N2) and influenza B viruses. Two-fourfold rise in hemagglutination-inhibition (HAI) titer was observed in 100% of the follow-up samples for influenza A(H1N1)pdm09 virus. No change in HAI titers for influenza A(H3N2) and influenza B viruses was observed.
机译:流感病毒是主要呼吸道病原体,导致季节性流行病和偶尔流行病。 对流感病毒的免疫应答主要是针对血凝素抗原的靶向。 基于实验室的回顾性横截面研究进行了50次急性和50个后续样本,以评估自然感染后对流感A(H1N1)PDM09病毒的免疫应答,并检测对甲型甲型A的预先存在的抗体(H3N2 )和流感b病毒。 在100%的流感A(H1N1)PDM09病毒的100%后续样品中观察到血凝抑制(HAI)滴度的两四倍。 观察到流感A(H3N2)和流感B病毒的HAI滴度没有变化。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号